Stay updated on Rilzabrutinib for CSU: H1 Resistant - Clinical Trial
Sign up to get notified when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.

Latest updates to the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s footer site revision was updated from v3.5.2 to v3.5.3, reflecting a website software release rather than any modification to the clinical trial information.SummaryDifference0.0%

- Check17 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded a revision notice: Revision: v3.4.3, and removed Revision: v3.4.2.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision from v3.4.1 to v3.4.2 appears to be a minor site version update with no changes to study content or page structure. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision: v3.4.1 is now displayed on the page, replacing Revision: v3.4.0.SummaryDifference0.0%

Stay in the know with updates to Rilzabrutinib for CSU: H1 Resistant - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.